Dafna Gladman, MD, Toronto Western Hospital, Toronto, ON, Canada; Christian Antoni, MD, Friedrich-Alexander University, Erlangen, Germany; Songkai Yan, PhD, Centcor, Inc., Malvern, PA, United States; Arthur Kavanaugh, MD, University of California, San Diego, La Jolla, CA, United StatesLe texte complet de cet article est disponible en PDF.
Dr. Gladman has participated in clinical trials. Dr. Antoni is an investigator and consultant for infliximab for Centocor. Dr. Kavanaugh has consulted and conducted clinical research sponsored by Centocor, Amgen Inc., and Abbott Laboratories.
Studies have been funded by research grants from Centocor (IMPACT) or have been done by Centocor (IMPACT 2).